Oxomemazine/guaifenesin
 | |
| Combination of | |
|---|---|
| Oxomemazine | H1 receptor antagonist (antihistamine) |
| Guaifenesin | expectorant |
| Clinical data | |
| Trade names | Toplexil and others |
| Routes of administration | Oral |
| ATC code |
|
| Identifiers | |
| CAS Number |
|
Oxomemazine/guaifenesin is a sedative antihistamine plus expectorant.[1][2] It is a combination of oxomemazine and guaifenesin.
It is sold under a variety of brand names including Toplexil by Aventis. It is sold over the counter in France, Egypt, Algeria, South Korea and the UAE[citation needed]. The oxomemazine ingredient (antihistamine) is not approved by the U.S. Food and Drug Administration (FDA), either for over the counter or prescription use. French travelers use it as a sleeping aid for long flights.[citation needed]
References[]
- ^ Oxomemazine, drugs.com
- ^ Toplexil, drugs.com
 | This pharmacology-related article is a stub. You can help Wikipedia by . |
Categories:
- Drugs not assigned an ATC code
- Combination drugs
- H1 receptor antagonists
- Sanofi
- Sedatives
- Pharmacology stubs